Literature DB >> 12792702

The effects of 2,3-diphosphoglycerate, adenosine triphosphate, and glycosylated hemoglobin on the hemoglobin-oxygen affinity of diabetic patients.

E M Castilho1, M L Glass, J C Manço.   

Abstract

The position of the oxygen dissociation curve (ODC) is modulated by 2,3-diphosphoglycerate (2,3-DPG). Decreases in 2,3-DPG concentration within the red cell shift the curve to the left, whereas increases in concentration cause a shift to the right of the ODC. Some earlier studies on diabetic patients have reported that insulin treatment may reduce the red cell concentrations of 2,3-DPG, causing a shift of the ODC to the left, but the reports are contradictory. Three groups were compared in the present study: 1) nondiabetic control individuals (N = 19); 2) insulin-dependent diabetes mellitus (IDDM) patients (on insulin treatment) (N = 19); 3) non-insulin-dependent diabetes mellitus (NIDDM) patients using oral hypoglycemic agents and no insulin treatment (N = 22). The overall position of the ODC was the same for the three groups despite an increase of the glycosylated hemoglobin fraction that was expected to shift the ODC to the left in both groups of diabetic patients (HbA1c: control, 4.6%; IDDM, 10.5%; NIDDM, 9.0%). In IDDM patients, the effect of the glycosylated hemoglobin fraction on the position of the ODC appeared to be counterbalanced by small though statistically significant increases in 2,3-DPG concentration from 2.05 (control) to 2.45 mol/ml blood (IDDM). Though not statistically significant, an increase of 2,3-DPG also occurred in NIDDM patients, while red cell ATP levels were the same for all groups. The positions of the ODC were the same for control subjects, IDDM and NIDDM patients. Thus, the PO2 at 50% hemoglobin-oxygen saturation was 26.8, 28.2 and 28.5 mmHg for control, IDDM and NIDDM, respectively. In conclusion, our data question the idea of adverse side effects of insulin treatment on oxygen transport. In other words, the shift to the left reported by others to be caused by insulin treatment was not detected.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12792702     DOI: 10.1590/s0100-879x2003000600008

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  6 in total

1.  The correlation of hemoglobin A1c to blood glucose.

Authors:  Ken Sikaris
Journal:  J Diabetes Sci Technol       Date:  2009-05-01

2.  Benefit of magnesium-25 carrying porphyrin-fullerene nanoparticles in experimental diabetic neuropathy.

Authors:  Asieh Hosseini; Mohammad Sharifzadeh; Seyed Mahdi Rezayat; Gholamreza Hassanzadeh; Shokoufeh Hassani; Maryam Baeeri; Vahid Shetab-Bushehri; Dmitry A Kuznetsov; Mohammad Abdollahi
Journal:  Int J Nanomedicine       Date:  2010-08-09

3.  Scintigraphy evaluation of hyperthyroidism and its correlation with clinical and biochemical profiles.

Authors:  Khaled Alswat; Sara Ahmad Assiri; Raad M M Althaqafi; Atheer Alsufyani; Abaad Althagafi; Sara Alrebaiee; Najd Alsukhayri
Journal:  BMC Res Notes       Date:  2020-07-06

4.  Dynamics of camel and human hemoglobin revealed by molecular simulations.

Authors:  Amanat Ali; Soja Saghar Soman; Ranjit Vijayan
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

5.  Analysis of Red Blood Cells and their Components in Medical Workers with Occupational Exposure to Low-Dose Ionizing Radiation.

Authors:  Xue-Lei Tian; Xue Lu; Yu-Min Lyu; Hua Zhao; Qing-Jie Liu; Mei Tian
Journal:  Dose Response       Date:  2022-02-24       Impact factor: 2.658

6.  Relating Retinal Vascular Oxygen Saturation and Microvasculature Morphology at Progressive Stages of Diabetic Retinopathy.

Authors:  Selin L Auvazian; Jennifer Cano; Sophie Leahy; Preny Karamian; Amir Kashani; Andrew Moshfeghi; Hossein Ameri; Norman P Blair; Mahnaz Shahidi
Journal:  Transl Vis Sci Technol       Date:  2021-05-03       Impact factor: 3.283

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.